Autologous stem cell transplantation improves microcirculation in systemic sclerosis

被引:80
|
作者
Miniati, I. [1 ]
Guiducci, S. [1 ]
Conforti, M. L. [1 ]
Rogai, V. [1 ]
Fiori, G. [1 ]
Cinelli, M. [1 ]
Saccardi, R. [2 ]
Guidi, S. [2 ]
Bosi, A. [2 ]
Tyndall, A. [3 ]
Matucci-Cerinic, M. [1 ]
机构
[1] AOUC, Dept Biomed, Div Rheumatol, DENOthe Ctr, Florence, Italy
[2] AOUC, Bone Marrow Transplantat Unit, Florence, Italy
[3] Univ Basel, Dept Rheumatol, Basel, Switzerland
关键词
ENDOTHELIAL GROWTH-FACTOR; NAILFOLD CAPILLAROSCOPY; RAYNAUDS-PHENOMENON; PULMONARY-FIBROSIS; CYCLOPHOSPHAMIDE; SCLERODERMA; DISORDERS; PLACEBO; DISEASE; ANGIOGENESIS;
D O I
10.1136/ard.2007.082495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In systemic sclerosis (SSc) reduced capillary density decreases blood flow and leads to tissue ischaemia and fingertip ulcers. Nail fold videocapillaro-scopy (NVC) is a diagnostic and follow-up parameter useful to evaluate the severity, activity and the stage of SSc microvascular damage. Autologous haemopoietic stem cell transplantation (HSCT) is a new treatment for patients with severe diffuse cutaneous systemic sclerosis (dcSSc) refractory to conventional therapies. We aimed to evaluate the improvement of microvasculature after HSCT using NVC. Methods: A total of 16 patients with severe dcSSc with a "late'' videocapillaroscopy pattern underwent an immunesuppressive treatment: 6 were treated with HSCT and 10 with monthly pulse cyclophosphamide (CYC) 1 g for 6 months and then orally with 50 mg/day for further 6 months. NVC was performed before and after 3 months from the beginning of each treatment and then repeated every 3 months. Results: In all patients, before HSCT NVC showed large avascular areas and ramified capillaries and vascular architectural disorganisation ("late'' pattern). At 3 months after HSCT, the NVC pattern changed from "late'' into "active'', showing frequent giant capillaries (>6/mm) and haemorrhages, absence of avascular areas and angiogenesis phenomena; 1 year after HSCT, microvascular abnormalities were still in the "active'' pattern. In patients treated with CYC, no NVC modifications were observed during 24 months of follow-up and the pattern always remained "late''. Conclusions: These results indicate that HSCT with a high dose CYC regimen may foster vascular remodelling, while CYC at lower doses and with a chronic regimen does not influence the microvasculature.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 50 条
  • [31] Stem cell transplantation in systemic sclerosis
    van Laar, Jacob M.
    Sullivan, Keith
    CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (06) : 719 - 725
  • [32] Stem Cell Transplantation in systemic Sclerosis??
    Ruchalla, Elke
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (21) : 1094 - 1094
  • [33] Autologous stem cell transplantation for multiple sclerosis
    Vereschagina, V.
    Totolyan, A.
    Bondarenko, N.
    Darskaya, E. I.
    Skoromets, A.
    Afanasyev, V.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S98 - S98
  • [34] Autologous stem cell transplantation in multiple sclerosis
    Barreira, Amilton A.
    Souza, Doralina G.
    Santos, Antonio C.
    Stracieri, Ana-Beatriz P.
    Oliveira, Maria-Carolina B.
    Godoi, Danielle E.
    Morais, Daniela A.
    Coutinho, Marina A.
    Marques, Wilson
    Voltarelli, Julio C.
    MULTIPLE SCLEROSIS, 2008, 14 : S15 - S15
  • [35] Hematopoietic Stem Cell Transplantation Improves Functional Outcomes of Systemic Sclerosis Patients
    Costa-Pereira, Karla R.
    Guimaraes, Ana Luisa
    Moraes, Daniela Aparecida
    Dias, Juliana Bernardes Elias
    Garcia, Juliana Tome
    de Oliveira-Cardoso, Erika Arantes
    Zombrilli, Andreia
    Leopoldo, Vanessa
    Costa, Thalita Melo
    Simoes, Belinda Pinto
    Oliveira, Maria Carolina
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : S131 - S138
  • [36] Autologous stem cell transplantation in systemic vasculitis
    Amberger, CC
    Daikeler, T
    Amberger, M
    Bocelli-Tyndall, C
    Tyndal, A
    Koetter, I
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 265 - 265
  • [37] HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SYSTEMIC SCLEROSIS (SSC)- THE ASTIS (AUTOLOGOUS STEM CELL TRANSPLANTATION INTERNATIONAL SCLERODERMA TRIAL) TRIAL
    Farge, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S92 - S92
  • [38] Mobilization with reduced cyclophosphamide for autologous stem cell transplantation is feasible in patients with systemic sclerosis
    Pecher, Ann-Christin
    Ach, Katharina Renate
    Vogel, Wichard
    Henes, Joerg Christoph
    RHEUMATOLOGY, 2023, 62 : SI107 - SI113
  • [39] COVID-19 infection after autologous stem cell transplantation for systemic sclerosis
    Henes, Joerg Christoph
    Martac, Ioana
    Vogel, Wichard
    Lengerke, Claudia
    Klein, Reinhild
    Hensen, Luca
    Pecher, Ann-Christin
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (07) : 996 - 998
  • [40] AUTOLOGOUS NON-MYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Milanetti, Francesca
    Bucha, Jurate
    Kwasny, Mary
    Boyce, Kristin
    Quigley, Kate
    Yaung, Kim
    Burt, Richard K.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S23 - S23